Please Wait.....
Report
Global Quantum Computing in Drug Discovery Market Report and Forecast 2024-2032
Market Report I 2023-09-25 I 140 Pages I EMR Inc.
Global Quantum Computing in Drug Discovery Market Report and Forecast 2024-2032
Global Quantum Computing in Drug Discovery Market Outlook
Quantum computing in drug discovery market was valued at USD 603.1 million in 2023, driven by the growing positive impact on the drug discovery process in pharmaceutical companies. The market size is anticipated to grow at a CAGR of 26% during the forecast period of 2024-2032 to achieve a value of USD 4,810.2 million by 2032.
Quantum Computing in Drug Discovery: Introduction
Quantum computing has the potential to revolutionize various fields, including drug discovery. While quantum computers are still in their infancy and not yet widely accessible, researchers are exploring their applications in drug discovery due to their ability to perform complex calculations at speeds that classical computers can't match. It is important to note that while quantum computing holds tremendous promise in drug discovery, practical applications are still in the experimental and theoretical stages. Building and maintaining quantum computers with the necessary qubits and minimizing error rates remain significant challenges. Additionally, quantum computers are not yet widely accessible to researchers in the field.
Key Trends in the Global Quantum Computing in Drug Discovery Market
Quantum computing in the drug discovery market has been experiencing significant growth and evolution in recent years. Several key trends are some key trends shaping the market:
- Increased Investment: There may have been increased investment from both public and private sectors in quantum computing technologies, including those applied to drug discovery. Governments, pharmaceutical companies, and tech giants might have dedicated more resources to quantum computing research and development.
- Partnerships and Collaborations: Collaboration between quantum computing companies and pharmaceutical firms could have become more common. These partnerships may aim to leverage the power of quantum computers for tasks such as simulating molecular interactions, drug optimization, and identifying potential candidates for drug development.
- Advanced Algorithms: Quantum algorithms specifically designed for drug discovery could have matured, allowing researchers to tackle complex problems more efficiently. Quantum machine learning techniques might have gained prominence in the field.
- Demonstrated Use Cases: There may have been more tangible demonstrations of quantum computing's value in drug discovery. Researchers might have showcased successful applications, such as simulating protein folding or predicting drug interactions.
- Rising Competition: The quantum computing market may have become more competitive, with various companies vying for dominance in the quantum drug discovery space. This competition could drive innovation and lower costs.
- Regulatory Considerations: Regulatory bodies might have started addressing the unique challenges and opportunities presented by quantum computing in the pharmaceutical industry. Guidelines and standards may have been developed to ensure the safe and effective use of quantum technologies in drug discovery.
Global Quantum Computing in Drug Discovery Market Segmentations
The market can be categorized into product and services, therapeutic areas, and regions.
Market Breakup by Product and Services
- Target Identification / Validation
- Hit Generation / Lead Identification
- Lead Optimization
Market Breakup by Therapeutic Area
- Cardiovascular Disorders
- CNS Disorders
- Dermatological Disorders
- Endocrine Disorders
- Gastrointestinal Disorders
- Immunological Disorders
- Infectious Diseases
- Musculoskeletal Disorders
- Oncological Disorders
- Respiratory Disorders
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Quantum Computing in Drug Discovery Market Overview
The quantum computing landscape in drug discovery is currently experiencing a dynamic and rapidly evolving phase. As of the present moment, quantum computing technology is making significant inroads into the pharmaceutical industry, promising to revolutionize the drug discovery process. Researchers and pharmaceutical companies are increasingly harnessing the power of quantum computers to tackle complex computational challenges that were previously insurmountable for classical computers. This includes simulating molecular structures and interactions with unprecedented accuracy, accelerating the drug discovery timeline, and potentially leading to the development of more effective and personalized medicines. The market for quantum computing in drug discovery is thus characterized by innovation, collaboration, and a growing interest from both established players and startups, all driven by the promising potential of quantum computing in advancing pharmaceutical research.
Key Players in the Global Quantum Computing in Drug Discovery Market
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the quantum computing in drug discovery market are as follows:
- Accenture
- Amazon Web Service
- Atos
- Fujitsu
- Huwaei
- IBM
- Microsoft
- Xanadu
- XtalPi
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1Preface
1.1Objectives of the Study
1.2Key Assumptions
1.3Report Coverage - Key Segmentation and Scope
1.4Research Methodology
2Executive Summary
3Global Quantum Computing in Drug Discovery Market Overview
3.1Global Quantum Computing in Drug Discovery Market Historical Value (2017-2023)
3.2Global Quantum Computing in Drug Discovery Market Forecast Value (2024-2032)
4Global Quantum Computing in Drug Discovery Market Landscape
4.1Global Quantum Computing in Drug Discovery: Developers Landscape
4.1.1Analysis by Year of Establishment
4.1.2Analysis by Company Size
4.1.3Analysis by Region
4.2Global Quantum Computing in Drug Discovery: Product Landscape
4.2.1Analysis by Type
4.2.2Analysis by Technology
4.2.3Analysis by Applications
5Global Quantum Computing in Drug Discovery Market Dynamics
5.1Market Drivers and Constraints
5.2SWOT Analysis
5.3Porter's Five Forces Model
5.4Key Demand Indicators
5.5Key Price Indicators
5.6Industry Events, Initiatives, and Trends
5.7Value Chain Analysis
6Global Quantum Computing in Drug Discovery Market Segmentation
6.1Global Quantum Computing in Drug Discovery Market by Product and Services
6.1.1Market Overview
6.1.2Target Identification / Validation
6.1.3Hit Generation / Lead Identification
6.1.4Lead Optimization
6.2Global Quantum Computing in Drug Discovery Market by Therapeutic Area
6.2.1Market Overview
6.2.2Cardiovascular Disorders
6.2.3CNS Disorders
6.2.4Dermatological Disorders
6.2.5Endocrine Disorders
6.2.6Gastrointestinal Disorders
6.2.7Immunological Disorders
6.2.8Infectious Diseases
6.2.9Musculoskeletal Disorders
6.2.10Oncological Disorders
6.2.11Respiratory Disorders
6.2.12Others
6.3Global Quantum Computing in Drug Discovery Market by Region
6.3.1Market Overview
6.3.2North America
6.3.3Europe
6.3.4Asia Pacific
6.3.5Latin America
6.3.6Middle East and Africa
7North America Quantum Computing in Drug Discovery Market
7.1Market Share by Country
7.2United States of America
7.3Canada
8Europe Quantum Computing in Drug Discovery Market
8.1Market Share by Country
8.2United Kingdom
8.3Germany
8.4France
8.5Italy
8.6Others
9Asia Pacific Quantum Computing in Drug Discovery Market
9.1Market Share by Country
9.2China
9.3Japan
9.4India
9.5ASEAN
9.6Australia
9.7Others
10Latin America Quantum Computing in Drug Discovery Market
10.1Market Share by Country
10.2Brazil
10.3Argentina
10.4Mexico
10.5Others
11Middle East and Africa Quantum Computing in Drug Discovery Market
11.1Market Share by Country
11.2Saudi Arabia
11.3United Arab Emirates
11.4Nigeria
11.5South Africa
11.6Others
12Regulatory Framework
12.1Regulatory Overview
12.1.1US FDA
12.1.2EU EMA
12.1.3INDIA CDSCO
12.1.4JAPAN PMDA
12.1.5Others
13Patent Analysis
13.1Analysis by Type of Patent
13.2Analysis by Publication year
13.3Analysis by Issuing Authority
13.4Analysis by Patent Age
13.5Analysis by CPC Analysis
13.6Analysis by Patent Valuation
13.7Analysis by Key Players
14Grants Analysis
14.1Analysis by year
14.2Analysis by Amount Awarded
14.3Analysis by Issuing Authority
14.4Analysis by Grant Application
14.5Analysis by Funding Institute
14.6Analysis by NIH Departments
14.7Analysis by Recipient Organization
15Funding and Investment Analysis
15.1Analysis by Funding Instances
15.2Analysis by Type of Funding
15.3Analysis by Funding Amount
15.4Analysis by Leading Players
15.5Analysis by Leading Investors
15.6Analysis by Geography
16Partnership and Collaborations Analysis
16.1Analysis by Partnership Instances
16.2Analysis by Type of Partnership
16.3Analysis by Leading Players
16.4Analysis by Geography
17Supplier Landscape
17.1Accenture
17.1.1Financial Analysis
17.1.2Product Portfolio
17.1.3Demographic Reach and Achievements
17.1.4Mergers and Acquisitions
17.1.5Certifications
17.2Amazon Web Service
17.2.1Financial Analysis
17.2.2Product Portfolio
17.2.3Demographic Reach and Achievements
17.2.4Mergers and Acquisitions
17.2.5Certifications
17.3Atos
17.3.1Financial Analysis
17.3.2Product Portfolio
17.3.3Demographic Reach and Achievements
17.3.4Mergers and Acquisitions
17.3.5Certifications
17.4Fujitsu
17.4.1Financial Analysis
17.4.2Product Portfolio
17.4.3Demographic Reach and Achievements
17.4.4Mergers and Acquisitions
17.4.5Certifications
17.5Huwaei
17.5.1Financial Analysis
17.5.2Product Portfolio
17.5.3Demographic Reach and Achievements
17.5.4Mergers and Acquisitions
17.5.5Certifications
17.6IBM
17.6.1Financial Analysis
17.6.2Product Portfolio
17.6.3Demographic Reach and Achievements
17.6.4Mergers and Acquisitions
17.6.5Certifications
17.7Microsoft
17.7.1Financial Analysis
17.7.2Product Portfolio
17.7.3Demographic Reach and Achievements
17.7.4Mergers and Acquisitions
17.7.5Certifications
17.8Xanadu
17.8.1Financial Analysis
17.8.2Product Portfolio
17.8.3Demographic Reach and Achievements
17.8.4Mergers and Acquisitions
17.8.5Certifications
17.9XtalPi
17.9.1Financial Analysis
17.9.2Product Portfolio
17.9.3Demographic Reach and Achievements
17.9.4Mergers and Acquisitions
17.9.5Certifications
18Key Opinion Leaders (KOL) Insights (Additional Insight)
19Company Competitiveness Analysis (Additional Insight)
19.1Very Small Companies
19.2Small Companies
19.3Mid-Sized Companies
19.4Large Companies
19.5Very Large Companies
20Payment Methods (Additional Insight)
20.1Government Funded
20.2Private Insurance
20.3Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security